Clinical trial
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or…
NCT00278434 · University of California, San Francisco, Other · Terminated
Key facts
| NCT number | NCT00278434 |
|---|---|
| Title | Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 |
| Official title | An Exploratory Clinical Trial of Zoledronic Acid in Women With CIN 2/3 or 3 |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Precancerous Condition |
| Intervention type | Drug, Other |
| Interventions | Zoledronate, Placebo (Saline) |
| Enrollment | 12 |
| Start date | Apr 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jan 18, 2006 |
| Last update posted | Nov 24, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: